Iovance Sparks More Optimism About Lifileucel’s Commercial Potential With New Analysis

 
• By Alaric DeArment
  
Iovance presented updated data from its Phase II study of lifileucel at SITC • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer